Septic shock attributed to Candida infection: Importance of empiric therapy and source control.
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Delayed treatment of candidemia has previously been shown to be an important determinant of patient outcome. However, septic shock attributed to Candida infection and its determinants of outcome have not been previously evaluated in a large patient population. METHODS: A retrospective cohort study of hospitalized patients with septic shock and blood cultures positive for Candida species was conducted at Barnes-Jewish Hospital, a 1250-bed urban teaching hospital (January 2002-December 2010). RESULTS: Two hundred twenty-four consecutive patients with septic shock and a positive blood culture for Candida species were identified. Death during hospitalization occurred among 155 (63.5%) patients. The hospital mortality rate for patients having adequate source control and antifungal therapy administered within 24 hours of the onset of shock was 52.8% (n = 142), compared to a mortality rate of 97.6% (n = 82) in patients who did not have these goals attained (P < .001). Multivariate logistic regression analysis demonstrated that delayed antifungal treatment (adjusted odds ratio [AOR], 33.75; 95% confidence interval [CI], 9.65-118.04; P = .005) and failure to achieve timely source control (AOR, 77.40; 95% CI, 21.52-278.38; P = .001) were independently associated with a greater risk of hospital mortality. CONCLUSIONS: The risk of death is exceptionally high among patients with septic shock attributed to Candida infection. Efforts aimed at timely source control and antifungal treatment are likely to be associated with improved clinical outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sepsis and septic shock due to fungi are most commonly observed in ICUs and are associated with poor outcomes [166–170].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [167]
In the citing paper
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association [167, 171–173].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [167]
In the citing paper
“This association is particularly pronounced for patients with candidemia and septic shock, for whom initiation of antifungal treatment more than 24 h after the onset of shock is associated with a mortality rate of nearly 100% [73].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [73]
In the citing paper
“There is compelling evidence that CVC removal is associated with higher rates of treatment success and lower mortality rates as compared with CVC retention [73,84,88,96,97].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [73]
Citations
Cites
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Self-citationInternational Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Self-citation
Research works printed but not linked: 1
- Guzman, 2011, 3, 65
Cited by
Items 101–200 of 532
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 59
Savage, R., Fowler, R., Rishu, A. H., Bagshaw, S. M., Cook, D., Dodek, P., Hall, R., Kumar, A., Lamontagne, F., Lauzier, F., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154944 · Cited by 57
Self-citationCortés, J. A., Reyes, P., Gómez, C., Cuervo, S. I., Rivas, P., Casas, C. A., & Sánchez, R. (2014) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2014.06.009 · Cited by 57
Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey
Kutlu, M., Kutlu, S. S., Çavuş, S. A., Öztürk, Ş. B., Tasbakan, M. I., Özhak, B., Kaya, O., Kutsoylu, O. Ö. E., Akar, Ş. Ş., Turhan, Ö., et al. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04394-0 · Cited by 54
Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study
Keighley, C., Chen, S. C. A., Marriott, D. J. E., Pope, A. L., Chapman, B., Kennedy, K., Bak, N., Underwood, N., Wilson, H. L., McDonald, K., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4065-5 · Cited by 54
How much European prescribing physicians know about invasive fungal infections management?
Valerio, M., Vena, A., Bouza, E., Reiter, N., Viale, P., Hochreiter, M., Giannella, M., Muñóz, P., & on behalf the COMIC study group (Collaborative group on Mycosis) (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0809-z · Cited by 53
Zhang, J., Yan, W., Dong, Y., Luo, X., Miao, H., Maimaijuma, T., Xu, X., Jiang, H., Huang, Z., Qi, L., et al. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-1191 · Cited by 53
Candidemia: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment
Cabrera-Guerrero, J. P., García-Salazar, E., Hernández‐Silva, G., Herrera, A. C., Martínez-Herrera, E. O., Pinto‐Almazán, R., León, M. G. F.-D., & Castro-Fuentes, C. A. (2025) · Pathogens · doi:10.3390/pathogens14080806 · Cited by 52
Oliva, A., Rosa, F. G. D., Mikulska, M., Pea, F., Sanguinetti, M., Tascini, C., & Venditti, M. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2240956 · Cited by 51
Impact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection
Levinson, T., Dahan, A., Novikov, A., Paran, Y., Berman, J., & Ben‐Ami, R. (2021) · Mycoses · doi:10.1111/myc.13191 · Cited by 50
Our current clinical understanding of Candida biofilms: where are we two decades on?
Ramage, G., Borghi, E., Rodrigues, C. F., Kean, R., Williams, C., & Lopez-Ribot, J. L. (2023) · Apmis · doi:10.1111/apm.13310 · Cited by 50
T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications
Zacharioudakis, I. M., Zervou, F. N., & Mylonakis, E. E. (2018) · Journal of Fungi · doi:10.3390/jof4020045 · Cited by 50
Poissy, J., Sendid, B., Damiens, S., Ishibashi, K. I., François, N., Kauv, M., Favory, R., Mathieu, D., & Poulain, D. (2014) · Critical Care · doi:10.1186/cc13953 · Cited by 50
An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2013) · Infection · doi:10.1007/s15010-013-0558-0 · Cited by 49
Chiotos, K., Vendetti, N., Zaoutis, T. E., Baddley, J., Ostrosky-Zeichner, L., Pappas, P., & Fisher, B. T. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw305 · Cited by 48
Boonstra, J., van der Elst, K. C. M., Veringa, A., Jongedijk, E. M., Brüggemann, R. J. M., Koster, R. A., Kampinga, G. A., Kosterink, J. G. W., van der Werf, T. S., Zijlstra, J. G., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01398-17 · Cited by 48
How to Identify Invasive Candidemia in ICU—A Narrative Review
Alves, J., Alonso-Tarrés, C., & Rello, J. (2022) · Antibiotics · doi:10.3390/antibiotics11121804 · Cited by 48
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
Fungal infections in the ICU: advances in treatment and diagnosis
PASCALE, G. D., & Tumbarello, M. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000230 · Cited by 47
Kumar, A., Zarychanski, R., Pisipati, A., Kumar, A., Kethireddy, S., & Bow, E. J. (2018) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2017.1421592 · Cited by 47
Self-citationFochtmann‐Frana, A., Freystätter, C., Vorstandlechner, V., Barth, A. C. R., Bolliger, M. J., Presterl, E., Ihra, G. C., Muschitz, G. K., Mittlboeck, M., Makristathis, A., et al. (2018) · Burns · doi:10.1016/j.burns.2017.12.009 · Cited by 47
Bassetti, M., Vena, A., Meroi, M., Cardozo, C., Cuervo, G., Giacobbe, D. R., Salavert, M., Merino, P., Gioia, F., Fernández‐Ruiz, M., et al. (2020) · Critical Care · doi:10.1186/s13054-020-2793-y · Cited by 46
Montravers, P., Pérrigault, P.-F., Timsit, J., Mira, J. P., Lortholary, O., Leroy, O., Gangneux, J., Guillemot, D., Bensoussan, C., Bailly, S., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.10.001 · Cited by 45
Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children
Gastine, S., Lehrnbecher, T., Müller, C., Farowski, F., Bader, P., Ullmann-Moskovits, J., Cornely, O. A., Groll, A. H., & Hempel, G. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01194-17 · Cited by 45
for the COMIC Study Group, Vena, A., Bouza, E., Corisco, R., Machado, M., Valerio, M., Sánchez, C., & Muñoz, P. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00281-x · Cited by 45
Roger, C., Wallis, S. C., Müller, L., Saïssi, G., Lipman, J., Brüggemann, R. J. M., Lefrant, J., & Roberts, J. A. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0495-z · Cited by 45
Кirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 44
Asai, N., Ohashi, W., Sakanashi, D., Suematsu, H., Kato, H., Hagihara, M., Watanabe, H., Shiota, A., Koizumi, Y., Yamagishi, Y., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-020-05719-8 · Cited by 43
Increased presepsin levels are associated with the severity of fungal bloodstream infections
Bamba, Y., Moro, H., Aoki, N., Koizumi, T., Ohshima, Y., Watanabe, S., Sakagami, T., Koya, T., Takada, T., & Kikuchi, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206089 · Cited by 41
Farmakiotis, D., & Kontoyiannis, D. P. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13186 · Cited by 41
Florio, W., Tavanti, A., Ghelardi, E., & Lupetti, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02577 · Cited by 41
Infections in Heart and Lung Transplant Recipients
Alsaeed, M., & Husain, S. (2018) · Critical Care Clinics · doi:10.1016/j.ccc.2018.08.010 · Cited by 39
Duceau, B., Picard, M., Pirracchio, R., Wanquet, A., Pène, F., Merceron, S., Mokart, D., Moreau, A., Lengliné, É., Canet, E., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003687 · Cited by 39
Chen, C., & Hong, W. (2021) · Antibiotics · doi:10.3390/antibiotics10030311 · Cited by 39
Bayona, J. V. M., García, C. S., Tormo, N., Martín, A. V., Padrón, C. G., Rodríguez, J. C., Pemán, J., & Cardona, C. G. (2022) · Journal of Fungi · doi:10.3390/jof8030281 · Cited by 39
Usefulness of guideline recommendations for prognosis in patients with candidemia
Cuervo, G., García‐Vidal, C., Puig‐Asensio, M., Merino, P., Vena, A., Martín‐Peña, A., Montejo, J. M., Gaitán, A. C. R., Lázaro-Perona, F., Fortün, J., et al. (2018) · Medical Mycology · doi:10.1093/mmy/myy118 · Cited by 39
Invasive Candida Infections in Neonates after Major Surgery: Current Evidence and New Directions
Rose, D. U. D., Santisi, A., Ronchetti, M. P., Martini, L., Serafini, L., Betta, P., Maino, M., Cavigioli, F., Cocchi, I., Pugni, L., et al. (2021) · Pathogens · doi:10.3390/pathogens10030319 · Cited by 38
Guillamet, C. V., Vazquez, R., Micek, S. T., Ursu, O., & Kollef, M. H. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.03.010 · Cited by 38
Self-citationKaranja, C. W., Hong, W., Younis, W., Eldesouky, H. E., Seleem, M. N., & Cheng, J. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01798 · Cited by 38
Ten-year review of invasive Candida infections in a tertiary care center in Saudi Arabia
Omrani, A. S., Makkawy, E. A., Baig, K., Baredhwan, A. A., Almuthree, S. A., Elkhizzi, N. A., & Albarrak, A. M. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.6005 · Cited by 37
O’Leary, R., Einav, S., Léone, M., Madách, K., Martin, C., & Martín‐Loeches, I. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.11.020 · Cited by 36
Sbrana, F., Sozio, E., Bassetti, M., Ripoli, A., Pieralli, F., Azzini, A. M., Morettini, A., Nozzoli, C., Merelli, M., Rizzardo, S., et al. (2018) · Internal and Emergency Medicine · doi:10.1007/s11739-017-1783-9 · Cited by 36
Mete, B., Zerdali, E. Y., Aygün, G., Saltoğlu, N., Balkan, İ. İ., Karaali, R., Kaya, S. Y., Karaismailoglu, B., Kaya, A., Ürkmez, S., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03994-6 · Cited by 36
Huang, Y., Wang, F., Chen, Y., Huang, Y., Hsieh, M.-H., Hii, I.-M., Lee, Y.-L., Ho, M., Liu, C.-E., Chen, Y., et al. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.11.002 · Cited by 36
Badiee, P., Boekhout, T., Haddadi, P., Mohammadi, R., Ghadimi-Moghadam, A., Soltani, J., Mahmoudabadi, A. Z., Mousavi, S. A. A., Najafzadeh, M. J., Diba, K., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02453-22 · Cited by 36
Hao, J., Li, W., Wang, Y., Zhao, J., & Chen, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1271952 · Cited by 34
Emergency medicine updates: Management of sepsis and septic shock
Long, B., & Gottlieb, M. A. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.01.054 · Cited by 34
Lin, S., Chen, R., Zhu, S., Wang, H., Wang, L., Zou, J., Yan, J., Zhang, X., Farmakiotis, D., Tan, X., et al. (2018) · Mycopathologia · doi:10.1007/s11046-018-0258-5 · Cited by 33
de Almeida, B. G., Lemes, T. H., Byzynski, G., Paziani, M. H., Kress, M. R. V. Z., de Almeida, M. T. G., & Volanti, D. P. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b00091 · Cited by 33
Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?
Vázquez, J. A., Whitaker, L., & Zubovskaia, A. (2025) · Journal of Fungi · doi:10.3390/jof11040258 · Cited by 32
Essentials in Candida bloodstream infection
Mellinghoff, S. C., Cornely, O. A., & Jung, N. (2018) · Infection · doi:10.1007/s15010-018-1218-1 · Cited by 32
Kurland, S., Furebring, M., Löwdin, E., Eliasson, E., Nielsen, E. I., & Sjölin, J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02466-18 · Cited by 32
Schroeder, J. A., Wilson, C. M., & Pappas, P. G. (2024) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2024.11.007 · Cited by 31
Keane, S., Geoghegan, P., Póvoa, P. M. S. R., Nseir, S., Rodríguez, A. H., & Martín‐Loeches, I. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1528872 · Cited by 31
Caspofungin: a review of its characteristics, activity, and use in intensive care units
Hashemian, S. M. R., Farhadi, T., & Velayati, A. A. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1794817 · Cited by 31
Sasaki, J., Matsushima, A., Ikeda, H., Inoue, Y., Katahira, J., Kishibe, M., Kimura, C., Sato, Y., Takuma, K., Tanaka, K., et al. (2022) · Acute Medicine & Surgery · doi:10.1002/ams2.739 · Cited by 31
Recent advances in the treatment of life-threatening, invasive fungal infections
Drew, R. H., Townsend, M. L., Pound, M. W., Johnson, S. W., & Perfect, J. R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.838217 · Cited by 31
Invasive Candida Infections in the ICU: Diagnosis and Therapy
Hankovszky, P., Társy, D., Öveges, N., & Molnár, Z. (2015) · The Journal of Critical Care Medicine · doi:10.1515/jccm-2015-0025 · Cited by 31
Murakami, M., Komatsu, H., Sugiyama, M., Ichikawa, Y., Ide, K., Tsuchiya, R., Kunieda, K., Magishi, A., Akiyama, G., 三浦, 文., et al. (2018) · Journal of General and Family Medicine · doi:10.1002/jgf2.159 · Cited by 31
Idelevich, E. A., Grünastel, B., & Becker, K. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01787-16 · Cited by 30
Immunotherapy: a potential adjunctive treatment for fungal infection
Kullberg, B. J., van de Veerdonk, F. L., & Netea, M. G. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000105 · Cited by 30
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia
Cardozo, C., Cuervo, G., Salavert, M., Merino, P., Gioia, F., Fernández‐Ruiz, M., López-Cortés, L. E., Escolà‐Vergé, L., Montejo, M., Muñóz, P., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz491 · Cited by 29
D’Ordine, R. L., Garcia, K. A., Roy, J., Zhang, Y., Markley, B., & Finkelman, M. (2020) · Medical Mycology · doi:10.1093/mmy/myaa028 · Cited by 29
Ng, K. K., Schorr, C., Reboli, A. C., Zanotti, S. L., & Tsigrelis, C. (2015) · Scandinavian Journal of Infectious Diseases · doi:10.3109/23744235.2015.1028100 · Cited by 29
Breda, G. L., Tuon, F. F., Meis, J. F. G. M., Herkert, P. F., Hagen, F., de Oliveira, L. Z., Dias, V. D. C., da Cunha, C. A., & Queiroz‐Telles, F. (2017) · Medical Mycology · doi:10.1093/mmy/myx077 · Cited by 29
Tsai, M.-H., Hsu, J., Chu, S., Chang, P., Lai, M., Wu, I.-H., Huang, H., Chiang, M., Fu, R.-H., & Lu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-01123-6 · Cited by 27
Zhang, P., Li, H., Cheng, J., Sun, A., Wang, L., Мирчевска, Г., Calderone, R., & Li, D. (2017) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2017.11.002 · Cited by 27
Beltrán‐Partida, E., Valdez, B. S., Valdez-Salas, E., Cortez, G. P., & Nedev, N. (2019) · Journal of Nanomaterials · doi:10.1155/2019/5287632 · Cited by 27
Impact of Triazole Therapeutic Drug Monitoring Availability and Timing
McCreary, E. K., Bayless, M. L., Van, A. P., Lepak, A. J., Wiebe, D. A., Schulz, L. T., & Andes, D. R. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01245-19 · Cited by 27
Prastiyanto, M. E., Rohmah, N., EFENDI, L., ARIFIN, R., Wardoyo, F. A., Wilson, W., Mukaromah, A. H., Dewi, S. S., & Darmawati, S. (2021) · Biodiversitas Journal of Biological Diversity · doi:10.13057/biodiv/d220355 · Cited by 27
Vargas-Espíndola, L. A., Cuervo, S. I., Enciso-Olivera, J. L., Gómez-Rincón, J. C., Cetina, L. P. J., Sánchez, R., García-Guzmán, K., López-Mora, M. J., Álvarez, C., Cortés, J. A., et al. (2023) · Journal of Fungi · doi:10.3390/jof9040400 · Cited by 26
Candida haemulonii complex, an emerging threat from tropical regions?
Françoise, U., Desnos‐Ollivier, M., Govic, Y. L., Sitbon, K., Valentino, R., Peugny, S., Chouaki, T., Mazars, E., Paugam, A., Nicolas, M., et al. (2023) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011453 · Cited by 26
Severe Candida infections in critically ill patients with COVID-19
Koulenti, D., Karvouniaris, M., Paramythiotou, E., Koliakos, N. N., Μάρκου, Ν., Paranos, P., Meletiadis, J., & Blot, S. I. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.07.005 · Cited by 26
Ohki, S., Shime, N., Kosaka, T., & Fujita, N. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00450-7 · Cited by 26
Antibiotics for the critically ill: more than just selecting appropriate initial therapy
Kollef, M. H. (2013) · Critical Care · doi:10.1186/cc12698 · Cited by 26
Self-citationPoissy, J., Rouzé, A., Cornu, M., Nseir, S., & Sendid, B. (2022) · Journal of Fungi · doi:10.3390/jof8090946 · Cited by 25
Honoré, P. M., Girardis, M., Kollef, M. H., Cornely, O. A., Thompson, G. R., Bassetti, M., Soriano, À., Haihui, H., Vázquez, J. A., Kullberg, B. J., et al. (2024) · Critical Care · doi:10.1186/s13054-024-05117-5 · Cited by 25
Self-citationPushing the Limits of MALDI-TOF Mass Spectrometry: Beyond Fungal Species Identification
Rizzato, C., Lombardi, L., Zoppo, M., Lupetti, A., & Tavanti, A. (2015) · Journal of Fungi · doi:10.3390/jof1030367 · Cited by 25
Villalobos, J. M., Castro, J. A., Montoya, A. A. A., Peláez, M. C., Somogyi, T., & Sandoval, L. (2016) · Revista chilena de infectología · doi:10.4067/s0716-10182016000200005 · Cited by 25
Jaffal, K., Poissy, J., Rouzé, A., Préau, S., Sendid, B., Cornu, M., & Nseir, S. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0392-8 · Cited by 25
Sganga, G., Wang, M., Capparella, M. R., Tawadrous, M., Yan, J. L., Aram, J. A., & Montravers, P. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03617-9 · Cited by 25
Mazzanti, S., Brescini, L., Morroni, G., Orsetti, E., Pocognoli, A., Donati, A., Cerutti, E., Münch, C. M., Montalti, R., & Barchiesi, F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252165 · Cited by 25
The paradox of the evidence about invasive fungal infections prevention
Cortegiani, A., Russotto, V., Raineri, S. M., & Giarratano, A. (2016) · Critical Care · doi:10.1186/s13054-016-1284-7 · Cited by 25
Yan, T., Li, S., Ou, H., Zhu, S., Huang, L., & Wang, D. (2020) · World Journal of Surgery · doi:10.1007/s00268-020-05380-x · Cited by 24
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review
van Leer, B., van Rijsewijk, N. D., Nijsten, M. W., Slart, R. H. J. A., Pillay, J., & Glaudemans, A. W. J. M. (2023) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2023.05.003 · Cited by 24
Initial antifungal strategy does not correlate with mortality in patients with candidemia
Murri, R., Scoppettuolo, G., Ventura, G., Fabbiani, M., Giovannenze, F., Taccari, F., Milozzi, E., Posteraro, B., Sanguinetti, M., Cauda, R., et al. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2527-2 · Cited by 24
Armstrong-James, D. P. H., Koh, M., Ostermann, M., & Cockwell, P. (2020) · BMJ Case Reports · doi:10.1136/bcr-2019-233072 · Cited by 24
Andrade, J. T., Lima, W. G., Sousa, J. F., Saldanha, A. A., de Sá, N. P., Morais, F. B., Silva, M. K. P., Viana, G. H. R., Johann, S., Soares, A. C., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113048 · Cited by 24
GUIDANCE FOR IMPLEMENTING AN ANTIMICROBIAL STEWARDSHIP PROGRAM IN JAPAN
8学会合同抗微生物薬適正使用推進検討委員会 (2017) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.91.709 · Cited by 24
Rezafungin in special populations with candidaemia and/or invasive candidiasis
Cornely, O. A., Dupont, H., Mikulska, M., Rautemaa‐Richardson, R., García‐Vidal, C., Thompson, G. R., & Hoenigl, M. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106435 · Cited by 23
Viable quantitative PCR for assessing the response of Candida albicans to antifungal treatment
Agustí, G., Fittipaldi, M., Morató, J., & Codony, F. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4524-z · Cited by 23
González-Lara, M. F., Torres‐González, P., Cornejo‐Juárez, P., Velázquez-Acosta, C., Martínez‐Gamboa, A., Rangel‐Cordero, A., Bobadilla-del-Valle, M., Ostrosky-Zeichner, L. L., Ponce‐de‐León, A., & Sifuentes‐Osornio, J. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2846-2 · Cited by 24
Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control
Khardori, N. M. (2012) · Yearbook of Medicine · doi:10.1016/j.ymed.2012.08.033 · Cited by 23
Fisher, B. T., Vendetti, N., Bryan, M. W., Prasad, P. A., Localio, A. R., Damianos, A., Coffin, S. E., Bell, L. M., Walsh, T. J., Gross, R., et al. (2015) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piv048 · Cited by 23
Tiseo, G., Vena, A., Bassetti, M., Bartalucci, C., Cerchiaro, M., Cesaretti, M., Marchese, A. E., Pilato, V. D., Escribano, P., Forniti, A., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106586 · Cited by 22
Ito‐Takeichi, S., Niwa, T., Fujibayashi, A., Suzuki, K., Ohta, H., Niwa, A., Tsuchiya, M., Yamamoto, M., Hatakeyama, D., Suzuki, A., et al. (2019) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12809 · Cited by 22
Garbez, N., Mbatchi, L., Wallis, S. C., Müller, L., Lipman, J., Roberts, J. A., Lefrant, J., & Roger, C. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-021-01062-6 · Cited by 22
McKeating, C., White, P. L., Posso, R. B., Palmer, M., Johnson, E. M., & McMullan, R. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204692 · Cited by 22
Reuken, P. A., Kruis, W., Maaser, C., Teich, N., Büning, J., Preiß, J., Schmelz, R., Bruns, T., Fichtner‐Feigl, S., Stallmach, A., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy017 · Cited by 22
Infrastructure and Organization of Adult Intensive Care Units in Resource-Limited Settings
Papali, A. C., Adhikari, N. K. J., Diaz, J. V., Dondorp, A. M., Dünser, M. W., Jacob, S. T., Phua, J., Romain, M., & Schultz, M. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-03143-5_3 · Cited by 22
Metadata
- Authors
- Kollef, M., Micek, S., Hampton, N., Doherty, J. A., & Kumar, A.
- Affiliations
- Washington University in St. Louis (US)
- Barnes-Jewish Hospital (US)
- BJC HealthCare (US)
- University of Manitoba (CA)
- Corresponding author
- Kollef, M.
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-15
- Volume
- 54
- Issue
- 12
- Pages
- 1739-1746
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2161872635
- Cited by
- 477
- References
- 40
- Citations by year
- 2026: 23 · 2025: 30 · 2024: 24 · 2023: 30 · 2022: 35 · 2021: 48 · 2020: 35 · 2019: 35 · 2018: 40 · 2017: 50 · 2016: 32 · 2015: 40 · 2014: 32 · 2013: 17 · 2012: 5
- FWCI
- 20.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- septic shock, candidiasis, candidemia, empirical antifungal therapy, source control, in-hospital mortality, bloodstream infection, treatment timing
- MeSH terms
- Adult, Aged, Aged, 80 and over, Antifungal Agents, Blood, Candida, Candidiasis, Female, Hospitals, Teaching, Humans, Male, Middle Aged, Retrospective Studies, Shock, Septic, Urban Population, Cohort Studies, Survival Analysis, Treatment Outcome, Infection Control
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.